Molecular basis and clinical implication of podocyte MEF-p53 network in CKD pathogenesis
Project/Area Number |
17K08309
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Pharmacology in pharmacy
|
Research Institution | Kumamoto University |
Principal Investigator |
Suico Mary Ann Soten 熊本大学, 大学院生命科学研究部附属グローバル天然物科学研究センター, 助教 (20363525)
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | p53 / podocyte / CKD / MEF / モデルマウス / ポドサイト / 抗体 / FSGS / ノックアウトマウス / 薬理学 / 慢性腎疾患 |
Outline of Final Research Achievements |
In the present study, we mainly focused on the role of p53 in the regulation of podocyte in in vitro and in vivo models. By in vitro analysis, we proved that treatment of murine podocyte MPC-5 cells with p53 activator Nutlin-3alpha significantly increases podocyte-functional genes' expression. On the other hand, p53 deficient in the anti-Nephtin-induced nephropathy model did not affect kidney phenotypes. Overall, p53 is partly involved in nephropathy phenotype through podocye, but in vivo relevances need to be clarified in the future study.
|
Academic Significance and Societal Importance of the Research Achievements |
CKDは糖尿病性腎症や遺伝性の腎障害に分類されるが,これらをあわせた患者数は極めて多い.回復の見込みのある急性腎臓病の場合と異なり,CKDに対する有効な治療法は未だ開発されておらず,末期罹患患者は人工透析や腎移植を余儀なくされている.本研究の遂行は「CKDが転写因子p53のネットワークの異常に伴う疾患である」という極めてシンプルかつ新規性あるモデルの提唱に直結しており,新規治療標的としての有用性という観点からも極めて意義深い.特に,p53が癌のみならず腎臓病の治療標的となり得るという知見は既に開発されている様々なp53活性化剤の適応拡大にも繋がる可能性もあり,極めて有用な情報となりうる.
|
Report
(4 results)
Research Products
(49 results)
-
-
[Journal Article] Azithromycin Inhibits Constitutive Airway Epithelial Sodium Channel Activation <i>in Vitro</i> and Modulates Downstream Pathogenesis <i>in Vivo</i>2020
Author(s)
Haruka Fujikawa, Taise Kawakami, Ryunosuke Nakashima, Aoi Nasu, Shunsuke Kamei, Hirofumi Nohara, Yuka Eto, Keiko Ueno-Shuto, Toru Takeo, Naomi Nakagata, Mary Ann Suico, Hirofumi Kai, Tsuyoshi Shuto.
-
Journal Title
Biological and Pharmaceutical Bulletin
Volume: 43
Issue: 4
Pages: 725-730
DOI
NAID
ISSN
0918-6158, 1347-5215
Year and Date
2020-04-01
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Melinjo seed extract increases adiponectin multimerization in physiological and pathological conditions.2020
Author(s)
K. Oniki, T. Kawakami, A. Nakashima, K. Miyata, T. Watanabe, H. Fujikawa, R. Nakashima, A. Nasu, Y. Eto, N. Takahashi, H. Nohara, M. Ann Suico, S. Kotani, Y. Obata, Y. Sakamoto, Y. Seguchi, J. Saruwatari, T. Imafuku, H. Watanabe, T. Maruyama, H. Kai, T. Shuto
-
Journal Title
Scientific reports
Volume: 10
Issue: 1
Pages: 4313-4313
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Auto-measure emphysematous parameters and pathophysiological gene expression profiles in experimental mouse models of acute and chronic obstructive pulmonary diseases2019
Author(s)
Nakashima R, Kamei S, Nohara H, Fujikawa H, Maruta K, Kawakami T, Eto Y, Takahashi N, Suico M.A., Takeo T, Nakagawa N, Kai H, Shuto T.
-
Journal Title
Journal of Pharmacological Sciences
Volume: 140
Issue: 2
Pages: 113-119
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Transthyretin Amyloid Fibril Disrupting Activities of Extracts and Fractions from Juglans mandshurica Maxim. var. cordiformis (Makino) Kitam.2019
Author(s)
Chaudhary N., Sasaki, R., Shuto, T., Watanabe, M., Kawahara, T., Suico, M.A., Yokoyama, T., Mizuguchi, M., Kai, H., Devkota, H.
-
Journal Title
Molecules
Volume: 24
Issue: 3
Pages: 500-500
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] A split-luciferase-based trimer formation assay as a high-throughput screening platform for therapeutics in Alport syndrome2018
Author(s)
Kohei Omachi, Misato Kamura, Keisuke Teramoto, Haruka Kojima, Tsubasa Yokota, Shota Kaseda, Jun Kuwazuru, Ryosuke Fukuda, Kosuke Koyama, Shingo Matsuyama, Keishi Motomura, Tsuyoshi Shuto, Mary Ann Suico and Hirofumi Kai.
-
Journal Title
Cell Chem Biol.
Volume: 印刷中
Issue: 5
Pages: 634-643.e4
DOI
Related Report
Peer Reviewed
-
[Journal Article] STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.2018
Author(s)
Yokota T, Omachi K, Suico MA, Kamura M, Kojima H, Fukuda R, Motomura K, Teramoto K, Kaseda S, Kuwazuru J, Takeo T, Nakagata N, Shuto T, Kai H.
-
Journal Title
Nephrol Dial Transplant
Volume: 33(2)
Issue: 2
Pages: 214-223
DOI
Related Report
Peer Reviewed
-
[Journal Article] Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.2017
Author(s)
Yokota T, Omachi K, Suico MA, Kojima H, Kamura M, Teramoto K, Kaseda S, Kuwazuru J, Shuto T, Kai H.
-
Journal Title
PLoS One.
Volume: 12(9)
Issue: 9
Pages: e0183959-e0183959
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Therapeutic potential of metformin in novel COPD mouse model with diffuse-type emphysema2019
Author(s)
Ryunosuke Nakashima, Hirofumi Nohara, Shunsuke Kamei, Haruka Fujikawa, Kasumi Maruta, Taisei Kawakami, Yuka Eto, Noriki Takahashi, Aoi Nasu, Mary-Ann Suico, Hirofumi Kai, Tsuyoshi Shuto
Organizer
ASCB|EMBO 2019 meeting
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-